Research Projects

2020 Retrospective Research Projects:

  • Assessing for the Correlation Between Medication Risk Scores® and Adverse Drug Events Using Regression Analysis
  • Evaluating the Association Among the Medication Risk Score® and Hierarchical Condition Category Scores in a Program of All-Inclusive Care for the Elderly (PACE) Setting
  • Investigating the Impact of a Novel Training Protocol on the Time to Reconcile Medications in a National Medication Therapy Management Call Center Setting
  • Comparing the Predictive Strength of the LACE+ Index with the MedWise Rise Score® on Hospital Readmission Rates: A Non-inferiority Observational Study
  • Assessing the Rate of Medication Errors and Drug-Drug Interactions Identified in a Retail Community Setting: A Quality Improvement Study
  • Identifying the Effects of Drug Pricing and Cost Barriers on Medication Adherence
  • Impact of Telehealth Interventions on Medication Adherence for Patients with Type 2 Diabetes, Hypertension, and Dyslipidemia: A Systematic Review
  • Evaluating the Cost Effectiveness of Implementing an Administrative Advanced Pharmacy Practice Experience Pharmacist Position: A Quality Improvement Study
  • Comprehensive Medication Review Completion Rates in Medically Underserved Areas and Populations
  • Reduction in Anticholinergic Burden Related to Bladder Antimuscarinics for Patients in a Program of All-inclusive Care for the Elderly (PACE) Setting
  • Assessment of SOAP Notes to Characterize the Impact of Pharmacist’s Interventions with a Comprehensive Medication Review
  • Identifying and Reducing the Risks Associated with Chronic Opioid Use among Older Medicare Adults
  • Evaluating the Impact of Novel Medication Adherence Interventions on the Proportion of Days Covered Rate
  • Assessing the Root Cause of Medication Non-Adherence
  • Assessment of Clinical Outcomes Following a Pharmacist-Delivered Comprehensive Medication Review for Patients with Type 2 Diabetes and Dyslipidemia
  • Assessment of Mortality Rates in SARS-CoV-2 Infected Populations Treated with Repurposed Medications
  • Evaluating Medication Risk Management Program Outcomes and Efficiencies
  • Exploring the Value of an Outcomes Dashboard

2020 Prospective Research Projects:

  • A Critical Appraisal of Drug-Drug Interaction Databases
  • A Prospective Multicenter Cohort Study Evaluating the Characteristics and Clinical Implications of a Clinical Decision Support System and of Pharmacogenomic Information Relevant to Polypharmacy Actions in Patients with Advanced Illness Who Are Receiving Multiple Drugs for Pain or Other Diseases
  • An Observational Exploration of Various Medication Risk Scores Calculated from Electronic Health Record Data in a General Population and Correlated with Medical Outcomes
  • Predictive Value of MedWise Risk Score® and Pharmacogenomics on Health Outcomes in Patients with Type 2 Diabetes
  • Evaluating the Impact of CYP2D6 Guided Opioid Therapy on Pain Management in a Program of All-inclusive Care for the Elderly (PACE) Setting
  • An Observational Study of Drug-Drug Interactions Involving CYP2D6 among Chronic Opioid Users and their Potential Impact on Healthcare Costs
  • Investigating the Effect of a Novel Call Script on Comprehensive Medication Review Completion Rates in a National Medication Therapy Management Call Center Setting
  • Assessing the Relationship Between Board of Pharmacy Specialties Certification and Job Satisfaction: A Quality Improvement Study
  • An Observational Exploration of Various Medication Risk Scores® as a Predictive Value of Adverse Drug Event: Development and Validation of a Dose-Sensitive Anticholinergic and Sedative Composite Risk Score
  • Investigating the Impact of SARS-CoV-2 on Pharmacy Personnel and Sleep Quality
  • Torsadogenic Risk Evaluation of Physiological and Supraphysiological Medication Dosing
  • Evaluating Community Pharmacy Staff Perception of a Clinical Decision Support System
  • Effectiveness of a Clinical Decision Support System in Identifying Drug-Drug Interactions in a Medication Therapy Management Setting
  • Pharmacometrics Modeling and Simulation of Probe Drug Profiles Subjected to Competitive Inhibition under Various Drug Administration Conditions.
  • Pharmacometrics Modeling and Simulation of Probe Drug Profiles Subjected to Competitive Inhibition under Various Drug Administration Conditions.
  • Implementation of a pharmacist-driven antipsychotic deprescribing initiative in the program of all-inclusive care for the elderly (PACE) setting: a pilot study
  • Evaluating the Role and Value of a Clinical Pharmacist in a Concierge Primary Care Clinic
  • Program of All-Inclusive Care for the Elderly (PACE) Attributes Associated with Economic and Clinical Outcomes
  • SARS-CoV-2 Simulation of Risk of Adverse Drug Events Associated with the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults with Polypharmacy
  • Modulatory Role of Blood-Brain-Barrier and Enzymatic Activity in an Innovative Human Model of Cholinergic Drug Induced Dementia
  • Impact of metabolic syndrome (MetS)-mediated chronic inflammation on cytochrome P450 enzyme drug pharmacokinetics and pharmacodynamics for Alzheimer’s disease and comorbidities
  • Simulation of Risk of Adverse Drug Events Associated with the Initiation of Drugs Repurposed for the Treatment of SARS-CoV-2 in Adults with Polypharmacy Using Data from Large Medicare and Commercially Insured Populations
  • Evaluating the Impact of Pharmacist-Delivered Comprehensive Medication Reviews on National Quality Forum and Consumer Assessment of Healthcare Providers and Systems Scores in a Hospice Setting
  • Investigating the Impact of Pharmacist-Delivered Comprehensive Medication Reviews on Quality of Life Scores for Patients in a Federally Qualified Health Center Setting